Loading...

Upcoming Orders and Expansion Will Drive Global Technology Reach Forward

Published
24 Dec 24
Updated
09 Mar 26
Views
104
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-3.4%
7D
5.5%

Author's Valuation

SEK 2151.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 09 Mar 26

MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook

Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.

What's in the News

  • Mycronic issued earnings guidance for 2026, with expected net sales at SEK 8.25b (company guidance).
  • The company announced an annual dividend of SEK 3.25 per share, with payment scheduled for May 13, 2026, ex date May 7, 2026, and record date May 8, 2026 (company announcement).
  • Mycronic received a replacement order for a Prexision 8 Evo mask writer from an existing customer in Asia, valued in the range of US$21 million to US$24 million, with delivery planned for the first quarter of 2027 (client announcement).
  • The company received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (client announcement).
  • Mycronic received multiple mask writer orders in Asia, including an FPS 6100 Evo and an SLX system, with individual order values ranging from US$4 million to US$7 million and deliveries planned between the first and third quarters of 2026 (client announcements).

Valuation Changes

  • Fair Value: SEK 215.00 remains unchanged, so the assessed share value is stable in this update.
  • Discount Rate: The discount rate has fallen slightly from 6.56% to 6.48%, which modestly affects the present value calculations used in the model.
  • Revenue Growth: The revenue growth assumption is effectively unchanged at about 5.45%, indicating a consistent view on top line potential.
  • Net Profit Margin: The net profit margin assumption is stable at roughly 21.32%, suggesting similar expectations for future profitability.
  • Future P/E: The future P/E multiple has ticked down slightly from 25.56x to 25.50x, a small adjustment that does not materially change the overall valuation outcome.
2 viewsusers have viewed this narrative update

Key Takeaways

  • Mycronic's acquisitions and new technology launches are bolstering revenue and market position, particularly in the Global Technologies and display industries.
  • Strategic geographic expansion and increased R&D investments indicate potential for long-term revenue growth and market diversification.
  • The combination of tariffs, demand weakness, and currency fluctuations is leading to declining revenues and earnings instability in Mycronic's High Flex division.

Catalysts

About Mycronic
    Develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Mycronic's recent acquisitions, such as Hprobe and RoBAT, are expected to expand its offerings in the Global Technologies division with unique technologies for testing MRAM and PCBs, potentially leading to increased revenue and strengthened market position.
  • The successful launch of the Prexision 8000 Evo, a high-end machine for mask writing in the display industry, confirms alignment with industry needs, and its reception may drive future order volumes, positively impacting revenue and earnings.
  • Strong growth in the company's High Volume division, particularly in the Chinese domestic market, suggests potential for increased sales and revenue growth, supported by a robust order backlog.
  • Continued expansion into new regions, like Southeast Asia, for High Volume production indicates strategic geographic diversification, which may enhance revenue stability and long-term growth prospects.
  • Increased R&D investments in Pattern Generators, with a focus on new product development and market opportunities such as inspection and quality control, could support long-term revenue growth and competitive positioning.

Mycronic Earnings and Revenue Growth

Mycronic Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Mycronic's revenue will grow by 1.3% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 24.5% today to 21.2% in 3 years time.
  • Analysts expect earnings to reach SEK 1.8 billion (and earnings per share of SEK 9.53) by about August 2028, down from SEK 2.0 billion today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as SEK2.0 billion.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 30.2x on those 2028 earnings, up from 21.1x today. This future PE is greater than the current PE for the GB Electronic industry at 29.9x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.12%, as per the Simply Wall St company report.

Mycronic Future Earnings Per Share Growth

Mycronic Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • The impact of new tariffs in the U.S. has caused delays in deliveries within the High Flex division, negatively impacting quarterly earnings by SEK 15 million and potentially affecting future revenues due to hesitation in investments.
  • There is noted weakness in demand within the High Flex division, particularly in Europe, leading to a decrease in order intake by 12% and negatively impacting net sales and earnings.
  • The financial outlook is uncertain due to fluctuations in exchange rates and the potential indirect effects of tariffs, which could lead to lower projected sales and impact both revenue and net margins.
  • Uncertainty in the investment climate and potential hesitation to invest due to market conditions and currency fluctuations could lead to volatility in order intake and revenues, especially in divisions with shorter lead times like High Flex.
  • Dependency on a limited number of customers in some divisions, such as Die Bonding in the Global Technologies division, can lead to fluctuating order intake, impacting revenue stability and earnings.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of SEK229.5 for Mycronic based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be SEK8.4 billion, earnings will come to SEK1.8 billion, and it would be trading on a PE ratio of 30.2x, assuming you use a discount rate of 6.1%.
  • Given the current share price of SEK213.15, the analyst price target of SEK229.5 is 7.1% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Mycronic?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

SEK 161
FV
32.0% overvalued intrinsic discount
3.43%
Revenue growth p.a.
4
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
SEK 255
FV
16.7% undervalued intrinsic discount
3.55%
Revenue growth p.a.
9
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative